Studies on long‐term T‐cell‐mediated immunity to epstein‐barr virus in immunosuppressed renal allograft recipients
- 15 December 1981
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 28 (6), 705-709
- https://doi.org/10.1002/ijc.2910280608
Abstract
Peripheral blood lymphocytes from normal seropositive donors and renal transplant recipients on various immunosuppressive regimens have been tested for their ability to mount a cytotoxic response when cultured with autologous EB virus‐infected B cells and thereby to cause regression of proliferating B‐cell foci. Cultures from 10 normal seropositive donors all showed the normal pattern of regression. Lymphocytes from patients receiving Cyclosporin A therapy with or without prednisolone completely failed to cause regression, thus allowing B‐cell lines to proliferate unchecked. Cells from two of 17 patients treated with azathioprine and prednisone also failed to cause regression. The cells from the remaining 15 individuals showed regression responses varying from minimal to normal. These results suggest a mechanism by which EB virus‐related tumours may arise in immunosuppressed renal allograft recipients.This publication has 25 references indexed in Scilit:
- CYCLOSPORIN A AND EPSTEIN-BARR VIRUSThe Lancet, 1980
- Immunologic Phenotype in 30 Patients with Diffuse Large-Cell LymphomaNew England Journal of Medicine, 1980
- Suppression of in vitro lymphocyte reactivity by cyclosporin A: existence of a population of drug-resistant cytotoxic lymphocytesNature, 1980
- CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMAThe Lancet, 1980
- HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cellsNature, 1980
- Neutralizing Antibodies to Epstein-Barr Virus in Healthy Populations and Patients with Infectious MononucleosisThe Journal of Infectious Diseases, 1973
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973
- ORAL EXCRETION OF EPSTEIN-BARR VIRUS BY HEALTHY SUBJECTS AND PATIENTS WITH INFECTIOUS MONONUCLEOSISThe Lancet, 1972
- Clinically Evident, Non-terminal Infections with Herpesviruses and the Wart Virus in Immunosuppressed Renal Allograft RecipientsBMJ, 1970
- HERPES-SIMPLEX-VIRUS INFECTION AFTER RENAL TRANSPLANTATIONThe Lancet, 1969